Vision UK 2013 call for papers

Article

The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013 conference.

The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013 conference.

Vision UK 2013 will be held on 11 June at the Queen Elizabeth II Conference Centre, London, UK. Submissions should be abstracts that focus on the delivery of the UK Vision Strategy objectives and outcomes.

The posters will be on display for delegates to view for the duration of the conference. Awards for the best poster in each category will be presented at the close of the conference. Posters must be sent by 8 April 2013.

Anita Lightstone, UK Vision Strategy Programme Director and VISION 2020 UK Interim Chief Operations Officer, commented, "The posters provide an excellent opportunity for those in the sector to showcase their work and share best practice with their peers. It is through this shared learning that we can continue to develop robust tactics to achieve the UK Vision Strategy aims."

For further details about submissions and guidelines please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.